Wednesday, December 24, 2025 | 05:29 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Glaxosmithkline Pharmaceuticals Share Price

Know More
BSENSE

2,480.00-15.00 (-0.60%)

04:01 PM, 24-Dec-2025

2,486.90-13.30 (-0.53%)

03:47 PM, 24-Dec-2025

BSE : 500660

NSE : GLAXO

Sector : Health care

ISIN Code : INE159A01016

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 24-Dec-2025 | 04:01 PM IST

Market Cap (₹ Cr)

42,014

Traded Value (₹ Cr)

0.50

Volume (Shares)

1,997

Face Value (₹)

10

52-Week High (₹)

3,515.95

52-Week High Date

05-Jun-2025

52-Week Low (₹)

1,924.30

52-Week Low Date

03-Feb-2025

All Time High (₹)

3,515.95

All Time High Date

05-Jun-2025

All Time Low (₹)

12.88

All Time Low Date

19-Aug-1988

Glaxosmithkline Pharmaceuticals Ltd

GlaxoSmithKline Pharmaceuticals Limited was erstwhile incorporated as 'Glindia Limited' in November 1924. The Company' s name was changed to Glaxo (India) Limited' from Glindia Limited in year 1987 and further to 'GlaxoSmithKline Pharmaceuticals Limited' from Glaxo (India) Limited effective from October 22 2001. GlaxoSmithKline Pharmaceuticals Limi...
Read More

Glaxosmithkline Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

42,131

EPS - TTM (₹) [C]

56.39

P/E Ratio (X) [C]

44.10

Face Value (₹) 10
Latest Dividend (%)420.00
Latest Dividend Date 30-May-2025
Dividend Yield (%) 2.16
Book Value Share (₹) [C]100.80
P/B Ratio (₹) [C]24.67

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
SBI Midcap Fund (G) 308.34 12,00,000 1.32
SBI Midcap Fund (IDCW) 308.34 12,00,000 1.32
SBI Midcap Fund - Direct (G) 308.34 12,00,000 1.32
SBI Midcap Fund - Direct (IDCW) 308.34 12,00,000 1.32
Kotak Large & Midcap Fund (G) 282.65 11,00,000 0.94
Kotak Large & Midcap Fund (IDCW) 282.65 11,00,000 0.94
Kotak Large & Midcap Fund - Direct (G) 282.65 11,00,000 0.94
Kotak Large & Midcap Fund - Direct (IDCW) 282.65 11,00,000 0.94
Nippon India Pharma Fund (G) 234.65 9,13,226 2.77
Nippon India Pharma Fund (Bonus) 234.65 9,13,226 2.77

Load more

Research Reports

DateBrokerActionPrices(₹) Report
14-May-2025Motilal Oswal Neutral 3,040

Stock Strength

Today's Low/High (₹)

2,476.00

2,510.30

Week Low/High (₹)

2,476.00

2,595.00

Month Low/High (₹)

2,404.20

2,635.00

Year Low/High (₹)

1,921.00

3,516.00

All time Low/High (₹)

12.88

3,516.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-3.67%-3.71%1.00%1.25%
1 Month0.49%0.40%0.60%0.70%
3 Month-9.50%-9.45%4.52%4.33%
6 Month-22.94%-22.98%4.09%4.38%
1 Year9.79%9.82%8.84%10.18%
3 Year86.05%85.56%42.72%46.81%

Company Info

Company Information

Non Executive Director : Subesh Williams

Chairperson : Renu S Karnad

Independent Director : Sunita Maheshwari

Independent Director : Manu Anand

Managing Director : Bhushan Akshikar

Whole Time Director & Chief Financial Officer : J. Chandy

Company Sec. & Compli. Officer : A A Nadkarni

Independent Director : Somasundaram Palamadairamaswamy

Independent Director : Anup Wadhawan

Registered Office: GSK House, Dr Annie Besant Road Worli,Mumbai,Maharashtra-400030 Ph: 91-022-24959595

Email:askus@gsk.com; ajay.a.nadkarni@gsk.com

URL:http://www.gsk-india.com

FAQs about Glaxosmithkline Pharmaceuticals Ltd

1. What's the Glaxosmithkline Pharmaceuticals Ltd share price today?
Glaxosmithkline Pharmaceuticals Ltd share price was Rs 2,480.00 at 04:01 PM IST on 24th Dec 2025. Glaxosmithkline Pharmaceuticals Ltd share price was down by 0.60% from the previous closing price of Rs 2,495.00. Glaxosmithkline Pharmaceuticals Ltd share price trend:

  • Last 1 Month: Glaxosmithkline Pharmaceuticals Ltd share price moved up by 0.49% on BSE.
  • Last 3 Months: Glaxosmithkline Pharmaceuticals Ltd share price moved down by 9.50% on BSE.
  • Last 12 Months: Glaxosmithkline Pharmaceuticals Ltd share price moved up by 9.79% on BSE.
  • Last 3 Years: Glaxosmithkline Pharmaceuticals Ltd share price moved up by 86.05% on BSE.


2. How can I quickly analyse the performance of the Glaxosmithkline Pharmaceuticals Ltd stock?
The performance of the Glaxosmithkline Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 44.10
  • Price to book value ratio is 24.67
  • Dividend yield of 2.16
  • The EPS (trailing 12 months) of the Glaxosmithkline Pharmaceuticals Ltd stock is Rs 56.39


3. What is the market cap of Glaxosmithkline Pharmaceuticals Ltd?
Glaxosmithkline Pharmaceuticals Ltd has a market capitalisation of Rs 42,014 crore.


4. What is Glaxosmithkline Pharmaceuticals Ltd's 52-week high/low share price?
The Glaxosmithkline Pharmaceuticals Ltd’s 52-week high share price is Rs 3,515.95 and 52-week low share price is Rs 1,924.30.


5. Is the Glaxosmithkline Pharmaceuticals Ltd profitable?
On a consolidated basis, Glaxosmithkline Pharmaceuticals Ltd reported a profit of Rs 257.49 crore on a total income of Rs 1,016.15 crore for the quarter ended 2025.


6. Which are Glaxosmithkline Pharmaceuticals Ltd’s peers in the Health care sector?
Glaxosmithkline Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Laurus Labs, Glenmark Pharma., Biocon, Glaxosmi. Pharma, Anthem Bioscienc, Ipca Labs., Ajanta Pharma.


7. Who owns how much in Glaxosmithkline Pharmaceuticals Ltd?
Key changes to the Glaxosmithkline Pharmaceuticals Ltd shareholding are as follows:

  • Promoter holding in Glaxosmithkline Pharmaceuticals Ltd has gone up to 75.00 per cent as of Sep 2025 from 75.00 per cent as of Dec 2024.